Stellate GanglionNCT06742255
Stellate Ganglion Block in Longstanding Facial Nerve Palsy Patients
An observational study of Stellate Ganglion and Facial Palsy, run by Assiut University.
Trial summary
The goal of the present study is to verify the efficacy of stellate ganglion block (SGB) in the treatment of facial pain Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Stellate Ganglion, Facial Palsy, Pain Management
- What is being tested?
- Stellate Ganglion Block
- Type of treatment
- Injection or infusion
- How many people
- 34 participants
- Where
- No sites listed yet
- Study dates
- 20 Dec 2024to 20 Dec 2024
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: facial nerve palsy patients
Who may be able to join
- facial nerve palsy patients
Who cannot join
- light of a recent myocardial infarction.
- anticoagulant use
- glucoma
- lateral nerve palsy
- emphysema
- cardiac conduction abnormalities
Show all 12Show fewer
- active infection, flu, cold
- uncontrolled cough
- Fever
- Very high blood pressure or if you are on blood thinners.
- allergic reaction to local anesthetics
- Primary and secondary coagulopathy.
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
The goal of the present study is to verify the efficacy of stellate ganglion block (SGB) in the treatment of facial pain
- Conditions
- Stellate Ganglion, Facial Palsy, Pain Management
- Being tested
- Stellate Ganglion Block
- Keywords
- Stellate gangliom, Facial palsy
- Medical subject headings
- Facial Paralysis, Agnosia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Stellate Ganglion BlockDrug
Stellate ganglion block is an injection of local anesthetic at the level of the neck to target the stellate ganglion, a sympathetic ganglion to interrupt abnormal autonomically-mediated pain in patients resistant to medical treatment
| Study group | Role | What they receive |
|---|---|---|
| stellate ganglion block group | Not described Receives: Drug: Stellate Ganglion Block | |
| medical treatment group | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Primary outcome: Average motor conduction latency in six muscle of the face
Measured: 6 month
Secondary outcomes (1)
Improved muscle tone
facial muscles start to regain their strength improvement of muscle tone.
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted19 Dec 2024
- Study start20 Dec 2024 (estimated)
- Primary completion20 Dec 2024 (estimated)
- Study completion20 Dec 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (5)Papers the sponsor has linked to this study.
- Other trials for Stellate GanglionStudies of the same condition, open and under way.
- More trials run by Assiut UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 34 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Assiut University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Remonda zaki abdelnaeem zaki, Assiut University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06742255
- Sponsor's protocol ID
- Stellate ganglion facial palsy
- Status last verified
- Dec 2024
- First submitted
- 16 Dec 2024
- Last updated
- 19 Dec 2024
- Results posted
- No
- FDA-regulated drug
- Yes
- FDA-regulated device
- No
Publications
Piraccini E, Munakomi S, Chang KV. Stellate Ganglion Blocks. 2023 Aug 13. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK507798/
PubMed 29939575Wang D. Image Guidance Technologies for Interventional Pain Procedures: Ultrasound, Fluoroscopy, and CT. Curr Pain Headache Rep. 2018 Jan 26;22(1):6. doi: 10.1007/s11916-018-0660-1.
PubMed 29374352Kapral S, Krafft P, Gosch M, Fleischmann D, Weinstabl C. Ultrasound imaging for stellate ganglion block: direct visualization of puncture site and local anesthetic spread. A pilot study. Reg Anesth. 1995 Jul-Aug;20(4):323-8.
PubMed 7577781Abdi S, Zhou Y, Patel N, Saini B, Nelson J. A new and easy technique to block the stellate ganglion. Pain Physician. 2004 Jul;7(3):327-31.
PubMed 16858470Baig S, Moon JY, Shankar H. Review of Sympathetic Blocks: Anatomy, Sonoanatomy, Evidence, and Techniques. Reg Anesth Pain Med. 2017 May/Jun;42(3):377-391. doi: 10.1097/AAP.0000000000000591.
PubMed 28272291
Study at a glance
From the registry record, last updated by the sponsor on 19 Dec 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Stellate Ganglion Block in Longstanding Facial Nerve Palsy Patients
- ClinicalTrials.gov ID
- NCT06742255
- Acronym / sponsor ID
- Stellate ganglion facial palsy
- Conditions
- Stellate Ganglion, Facial Palsy, Pain Management
- Keywords
- Stellate gangliom, Facial palsy
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 34 participants (estimated)
- Lead sponsor
- Assiut UniversityUniversity, hospital or other
- Study start
- 20 Dec 2024 (estimated)
- Primary completion
- 20 Dec 2024 (estimated)
- Study completion
- 20 Dec 2024 (estimated)
- First posted
- 19 Dec 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of the present study is to verify the efficacy of stellate ganglion block (SGB) in the treatment of facial pain
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| stellate ganglion block group | – | Drug: Stellate Ganglion Block |
| medical treatment group | – | – |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- facial nerve palsy patients
Key inclusion criteria (1 listed)
- facial nerve palsy patients
Key exclusion criteria (12 listed)
- light of a recent myocardial infarction.
- anticoagulant use
- glucoma
- lateral nerve palsy
- emphysema
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Stellate Ganglion BlockStellate ganglion block is an injection of local anesthetic at the level of the neck to target the stellate ganglion, a sympathetic ganglion to interrupt abnormal autonomically-mediated pain in patients resistant to medical treatment | Drug | stellate ganglion block group |
Primary outcome
Primary outcome: Average motor conduction latency in six muscle of the face
Time frame: 6 month
1 secondary outcome
Improved muscle tone
Time frame: 6 months
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 19 Dec 2024.
- Results publication: PubMed 29939575Piraccini E, Munakomi S, Chang KV. Stellate Ganglion Blocks. 2023 Aug 13. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK507798/
- Results publication: PubMed 29374352Wang D. Image Guidance Technologies for Interventional Pain Procedures: Ultrasound, Fluoroscopy, and CT. Curr Pain Headache Rep. 2018 Jan 26;22(1):6. doi: 10.1007/s11916-018-0660-1.
- Results publication: PubMed 7577781Kapral S, Krafft P, Gosch M, Fleischmann D, Weinstabl C. Ultrasound imaging for stellate ganglion block: direct visualization of puncture site and local anesthetic spread. A pilot study. Reg Anesth. 1995 Jul-Aug;20(4):323-8.
- Results publication: PubMed 16858470Abdi S, Zhou Y, Patel N, Saini B, Nelson J. A new and easy technique to block the stellate ganglion. Pain Physician. 2004 Jul;7(3):327-31.
- Results publication: PubMed 28272291Baig S, Moon JY, Shankar H. Review of Sympathetic Blocks: Anatomy, Sonoanatomy, Evidence, and Techniques. Reg Anesth Pain Med. 2017 May/Jun;42(3):377-391. doi: 10.1097/AAP.0000000000000591.
Related trials for Stellate Ganglion
Recruiting
Ultrasound Guided Stellate Ganglion Block in Postural Tachycardia Syndrome
Postural Tachycardia Syndrome
Not yet recruiting
Stellate Ganglion Block on Postoperative Sleep Status in Patients With Prolonged Disorders of Consciousness
Stellate Ganglion Block, Prolonged Disorders of Consciousness
Not yet recruitingPhase 3
SGB for Prevention of Postop A-Fib After Cardiac SurgeryTrial
Atrial Fibrillation, Postoperative Atrial Fibrillation
Not yet recruiting
Noninvasive CA Monitoring Validation and Autonomic Modulation in Aneurysmal Subarachnoid Hemorrhage
Subarachnoid Hemorrhage, Aneurysmal, Delayed Cerebral Ischemia
Not yet recruiting
Effect of Stellate Ganglion Block on Sleep Quality in Patients With Depression
Sleep and Circadian Problems
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
An observational study of Stellate Ganglion and Facial Palsy, run by Assiut University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 19 Dec 2024. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Remonda Zaki Abd El Naeem (+201200184996, mondazaki1996@gmai.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Primary outcome: Average motor conduction latency in six muscle of the face (time frame: 6 month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT06742255, which also lists 5 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Dec 2024.